An Overview of FDA Approved Liposome Formulations for Cancer Therapy
Journal of Advances in Medical and Pharmaceutical Sciences · pp. 1–7 · Published 19 Apr 2022
10.9734/jamps/2022/v24i330288Abstract
One of the early achievements of researchers to develop Nano drug delivery systems were successfully manifested in the form of liposomes. Since the time of its invention in 1965, many technological advancements have been witnessed in Liposomal drug delivery systems, which are a field of study. The capacity to change a drug's biodistribution profile, liposomes have been reported to enhance and improve the therapeutic index of different drugs. Drugs of various categories like antineoplastic, antifungal agents, and Anti-inflammatory agents properties and therapy genes have been extensively studied for efficient delivery using liposomes. US-FDA-approved products like Doxil®, Ambisome®, DepoDur™, etc have been seen to play an important part in the treating of a large number of patients across the world. This review aims to provide updated information about various approved and marketed liposome formulations and their role in the modern-day health care systems.
References (18)
- 1 Liposomal Formulations in Clinical Use: An Updated Review [DOI]
- 2 Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
- 3 Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy [DOI]
- 4 Liposomes : a practical approach
- 5 Liposomal daunorubicin as treatment for Kaposi’s sarcoma [DOI]
- 6 Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects [DOI]
- 7 Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. [DOI]
- 8 Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors.
- 9 Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
- 10 Extended CSF cytarabine exposure following intrathecal administration of DTC 101. [DOI]
- 11 Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations [DOI]
- 12 Clinical Pharmacology of Encapsulated Sustained-Release Cytarabine [DOI]
- 13 Cardiac safety of liposomal anthracyclines [DOI]
- 14 Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin [DOI]
- 15 Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).
- 16 The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma [DOI]
- 17 Liposomal anthracyclines for breast cancer [DOI]
- 18 Clinical Pharmacology of Encapsulated Sustained-Release Cytarabine [DOI]
Cited by 29
Gitanjali Sahu, Krishna Sanka, Ravi Arukula · Analytical Chemistry Letters · 2025
Raj Patel, Dhruvi Patel, Unnati Dani · Journal of Cardiology · 2026
Surendra S. Agrawal, Vrinda Baliga, Vaishali Y. Londhe · Pharmaceutics · 2024
Omotola D. Gbadegesin, Simeon K. Adesina · International Journal of Molecular Sciences · 2025
Fatih Ciftci, Ali Can Özarslan, İmran Cagri Kantarci · Pharmaceutics · 2025
Rahul Maheshwari, Devesh Kapoor, Suryanarayana Polaka · Molecular Pharmaceutics · 2025
Ayushi Pradhan, Gurudutta Pattnaik, Shubhashree Das · Medical Oncology · 2025
Safal Kumar Paikray, Liza Sahoo, Nigam Sekhar Tripathy · Current Pharmaceutical Biotechnology · 2025
George-Alexandru Croitoru, Adelina-Gabriela Niculescu, Dragoș Epistatu · Applied Sciences · 2024
Bruna de Almeida Rocha, Letícia Aparecida de Morais, Mateus Costa Viana · Cancer Therapy · 2024
Showing 13 of 29 known citations — external sources report more than can currently be individually listed.
Related research
- Design of Sustainable Copper-Based Hybrid Catalyst Using Aqueous Extract of Curcuma longa L. for One-Pot Synthesis of 1,2,3-Triazole — shares topic coverage
- Crystalline Copper Nanomaterials for Advanced Ceramic: A Comprehensive Review for Functional Ceramic Coating Approaches — shares topic coverage
- Nanomaterials Life Cycle Analysis: Health and Safety Practices, Standards and Regulations – Past, Present and Future Perspective — shares topic coverage
- Determination of Optical Band Gap Energy of Wurtzite ZnO: Ce Nanocrystallites — shares topic coverage
- Preparation and Testing the Hyperthermia Property of Electrospun Micro and Nanofibers — shares topic coverage
Article metrics
Real usage data collected on this platform.
91
Page views
0
PDF downloads
12
Outbound clicks
29
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.